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Abstract
Objectives: Drug overdose is the second leading cause of accidental deaths among U.S. adults aged 15–64
years. Emergency physicians have a unique opportunity to provide overdose prevention interventions,
because habitual drug users are in frequent need of medical care. The authors evaluated associations
between individual-level risk factors and experiencing an overdose in the past six months to determine
which characteristics and behaviors may be most predictive of overdose.
Methods: The authors used data from a sample of street-recruited habitual drug users who participated in
face-to-face interviews about overdose from November 2001 to February 2004. This analysis was restricted
to 772 respondents who had been injecting for at least one year and who had injected heroin within the past
two months.
Results: A total of 16.6% of participants had overdosed in the past six months. Characteristics and behav-
iors that were independently associated with an increased risk of a recent overdose were having had a
prior overdose (odds ratio [OR], 28.58; 95% confidence interval [CI] = 14.10 to 57.96), using cocaine/crack
in the past six months (OR, 2.07; 95% CI = 1.25 to 3.45), using alcohol in the past six months (OR, 1.90;
95% CI = 1.01 to 3.57), experiencing serious withdrawal symptoms in the past two months (OR, 2.70; 95%
CI = 1.58 to 4.61), and younger age.
Conclusions: Drug users who have previously experienced a nonfatal overdose are at very high risk of expe-
riencing future overdoses. Further longitudinal studies are needed to identify robust predictors of overdose
risk over time in habitual drug users, but these data suggest that drug users who have overdosed warrant
aggressive prevention efforts such as agonist maintenance treatment or provision of take-home naloxone.
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verdose is the second leading cause of accidental
death among U.S. adults aged 15–64 years1 and
the leading cause of death among drug users.2
Death rates from overdose have continued to climb in
many regions,1,3 and more than two thirds of drug users
report at least one nonfatal overdose in their lifetime.4
There were more than two million drug-related emer-
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is associated with substantial morbidity (e.g., physical
injuries, aspiration-related lung injury and infections,
seizures, and peripheral neuropathy).6
Demographic, health, and drug use characteristics and
risk behaviors are associated with an increased risk of
overdose. Indicators of social marginalization, including
homelessness,7,8 Axis I and II mental health disorders
and feelings of hopelessness,9–11 and antisocial behav-
ior,12 have been associated with drug overdose. Overdose
death is more likely following human immunodeficiency
virus (HIV) seroconversion and among those with abnor-
mal liver function, shortness of breath, and diarrhea,13
suggesting that common mechanisms of overdose death
(respiratory depression and cardiac arrest)14 may be
more likely in individuals with systemic comorbidities.
Length of drug use,4,15 polydrug use,4,16–18 risky drug
use,13,15,19 disrupted life circumstances,20,21 and conflicts
within social networks19 are associated with overdose.
Risk of overdose increases with periods of reduced toler-
ance, including release from prison22 and naltrexone
detoxification,23 while overdose risk is decreased withª 2007 by the Society for Academic Emergency Medicine
doi: 10.1197/j.aem.2007.04.005
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hair of overdose decedents are far below the levels of
active heroin users,25,26 suggesting periods of abstinence
preceding death. Drug dependence may have a more
complicated relationship with overdose, with heroin de-
pendence possibly protecting users through increased
tolerance and cocaine dependence resulting in direct tox-
icity.27 Few studies have looked at the breadth of potential
risk factors together in one sample of habitual drug users
while also controlling for history of overdose, which may
be an important predictor of future overdose.24,28
Interventions for opioid overdose prevention include
expanded access to opioid agonist maintenance treat-
ment, training in rescue breathing, and prescription of
take-home naloxone, the latter of which has been adop-
ted by numerous departments of health and a growing
number of medical providers.29–31 To help physicians tar-
get patients in need of overdose prevention messages,
we evaluated the associations between a variety of indi-
vidual-level characteristics and behaviors hypothesized
to be related to overdose risk and developed a model pre-
dictive of recent overdose.
METHODS
Study Design
A cross-sectional study was conducted among current
drug users to assess risk factors for recent overdose.
The institutional review board at the New York Academy
of Medicine approved the study, and all study subjects
provided written consent at the time of the interview.
Study Setting and Population
Participants were recruited through targeted outreach
techniques (described elsewhere)32,33 from selected
neighborhoods in a large urban area in the United States
with high proportions of minority populations from No-
vember 2001 to February 2004. Eligibility requirements
included participants being 18 years of age or older and
having used heroin, crack, or cocaine at least once in
the two months before the interview.
Study Protocol
Structured in-person interviews were conducted in En-
glish or Spanish by trained interviewers at two stationary
storefronts in central Harlem (Manhattan) and the South
Bronx. Identifying information was collected from partic-
ipants to ensure that individuals did not participate more
than once in the study, but this information was kept sep-
arate from responses to the questionnaire to ensure ano-
nymity, linked only by a unique identification number
and stored in separate files. Data were entered and main-
tained electronically.
Measures
We assessed demographic characteristics (gender, age,
race/ethnicity, marital status, educational attainment,
and homelessness in the past six months), health status,
drug use, and risk behaviors previously shown to impact
overdose risk.
Overdose Experience. Consistent with investigations in
Adelaide, Australia,17 and San Francisco, California,18overdose was defined as ‘‘someone who collapses, has
blue skin color, convulsions, difficulty breathing, loses
consciousness, cannot be woken up, or has a heart attack
or dies while using drugs.’’ Respondents were asked if
they had ever overdosed during their lifetime; those
who had overdosed were asked how many times they
had overdosed in the past six months, in the past year,
and in their lifetime. For the purposes of this analysis, a
recent overdose was defined as experiencing at least
one overdose within the past six months, whereas a prior
overdose was defined as experiencing at least one over-
dose prior to the past six months. We also asked partici-
pants if they had ever seen someone else overdose and if
they had ever personally known anyone who died of a
drug overdose.
Health Status. Respondents were asked to rate their
overall health; responses of excellent, very good, and
good were grouped together, while responses of fair
and poor were grouped together to create a more clear
contrast between those with better and worse self-rated
health. Respondents were also asked to report their HIV
status (positive, negative, or unknown). Additionally, the
Medical Outcomes Survey Short-Form 36 (SF-36) was
used to assess health-related quality of life. Summary
scores were created for eight distinct components: phys-
ical functioning, role limitations due to physical prob-
lems, role limitations due to emotional problems, social
functioning, bodily pain, vitality, general health, and
mental health. Each measure was scored on a scale
from 0 to 100, with higher scores indicating better health.
These component scores have been repeatedly vali-
dated34–36 and have been successfully applied to drug
users in other studies.37
Drug Use and Risk Behaviors. Length of drug-using ca-
reer was calculated from the participants’ age of first use
and last use of drugs. We also assessed the use of specific
drugs in the past six months, including heroin, cocaine or
crack, alcohol, and tranquilizers or benzodiazepines, and
the number of types of drugs used in the past six months
(marijuana, heroin, crack, cocaine, alcohol, cigarettes,
methamphetamines, tranquilizers or barbiturates, hallu-
cinogens, or other drugs). The number of types of drugs
used in the past six months was categorized into two
groups (1–5, R6) to differentiate between those who
had and had not used more than the sample mean num-
ber of types of drugs.
Participants were asked about any risky practices they
had engaged in at their last injection, including splitting
drugs with someone else using a needle or sharing a
cooker, cotton, rinse water, or needle with someone
else. We also asked if participants had ever used a sy-
ringe exchange program. Finally, we asked about sexual
risk behaviors in the past two months, including having a
sexual partner with hepatitis, giving or receiving drugs
or money for sex, using condoms less than 80% of the
time with casual partners, or having more than the sam-
ple median number of sexual partners (>1).
We assessed heroin and cocaine dependence using the
Severity of Dependence Scale (SDS), a valid and reliable
measure that assesses the degree of psychological depen-
dence experienced by users of different types of illicit
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items: 1) ‘‘How often did you think your use of [named
drug] was out of control?,’’ 2) ‘‘How often did the pros-
pect of going without [named drug] make you very anx-
ious or worried?,’’ 3) ‘‘How much did you worry about
your [named drug] use?,’’ 4) ‘‘How often did you wish
you could stop?,’’ and 5) ‘‘How difficult would you find
it to stop or go without [named drug]?.’’ Each item was
scored on a four-point scale (for items 1–4: 0 = never/
almost never, 1 = sometimes, 2 = often, 3 = always/nearly
always; for item 5: 0 = not difficult, 1 = quite difficult, 2 =
very difficult, 3 = impossible). The total SDS score was ob-
tained by adding the scores of all items (range, 0–15), with
higher total scores indicating higher levels of depen-
dence. A test of the internal consistency of the scale
among five samples demonstrated Cronbach’s a values
between 0.80 and 0.90 and correlation levels between to-
tal scores and factor scores >0.99.38 The SDS can be
adapted to cover different types of drugs and different
time periods by modifying the reference to the named
drug and the specified time frame; we assessed heroin
and cocaine dependence in the past year. A study report-
ing on the psychometric properties of the SDS in samples
of heroin users showed that total SDS scores R7 were
generally indicative of severe heroin dependence.17,38,40
Another study of recent cocaine users showed that a total
SDS score of R3 discriminated best between the pres-
ence and absence of a Diagnostic and Statistical Manual
of Mental Disorders, 4th Edition (DSM-IV) diagnosis of
cocaine dependence.41 Consistent with these findings,
we considered scores R7 and R3 as indicative of depen-
dence on heroin and cocaine, respectively.
Serious withdrawal symptoms in the past two months
were also assessed; examples of serious withdrawal
symptoms provided to participants included stomach
cramps, diarrhea, vomiting, and sweating. Finally, we
asked about participation in drug treatment during the
past six months, including methadone maintenance, de-
toxification, and other drug treatment programs includ-
ing Narcotics Anonymous and therapeutic communities.
Data Analysis
This analysis was restricted to participants who reported
a drug injection career of at least one year and who had
injected heroin in the past two months to assess determi-
nants of recent overdose among long-term habitual drug
users rather than new or less frequent users. We re-
stricted the analysis to heroin users to facilitate compar-
isons with other studies. We described the demographic
characteristics, health status, drug use and risk behav-
iors, and overdose experience of the participants. We
calculated the prevalence of recent overdose and com-
pared characteristics of those who had and had not
experienced a recent overdose. Finally, we created a
multivariable logistic regression model, including all var-
iables that significantly improved model fit using log like-
lihood ratio tests to build the best model predictive of
recent overdose. The predictive ability of the model
was assessed using the c-statistic, which corresponds
to the area under the receiver operating characteristic
curve.42 Higher values of the c-statistic indicate better
predictive ability, with a value of 0.5 indicating no predic-
tive ability and a value of 1.0 indicating perfect predictiveability.43 All measures described here and listed in Table 1
were considered as potential covariates for the multi-
variable model. Odds ratios (ORs) and 95% confidence
intervals (CIs) were calculated for all variables in the
multivariable model. All analyses were performed with
the SAS version 8.01 software package (SAS Institute,
Inc., Cary, NC).
RESULTS
We analyzed data from 772 participants who had injected
for at least one year and who had injected heroin within
the past two months. Most respondents were male, 25–44
years of age, Hispanic, and unmarried, and about half
had less than a high school education (Table 1). The ma-
jority reported their general health to be fair or poor;
11.5% were HIV positive, and 12.6% did not know their
HIV status. Most had been using drugs for more than
ten years, had used cocaine or crack and alcohol in the
past six months, and reported using six or more types
of drugs in the past six months. Just less than half re-
ported at least one risky injection practice at their last
injection, nearly 60% had used a needle exchange
program, and about half reported risky sex in the past
two months. The majority of participants were severely
dependent on heroin and on cocaine, and more than
one third had experienced serious withdrawal symptoms
in the past two months. A history of drug treatment was
common, with about 40% reporting methadone mainte-
nance and 61% reporting detoxification in the past six
months. More than two thirds of participants had ever
witnessed an overdose and had personally known some-
one who died of an overdose.
Overall, 16.6% of respondents had experienced an
overdose in the past six months (Table 1). A greater pro-
portion of those who recently overdosed than those who
did not were male, younger, and recently homeless. Re-
cent overdose was also associated with poorer self-
reported health and limitations due to physical and
emotional problems, social functioning, pain, general
and mental health, and use of other drugs in addition
to heroin during the past six months. Those with a recent
overdose were also more likely to have engaged in risky
injection and sexual behaviors, were less likely to have
ever used a needle exchange, and were more likely to
have recently experienced serious withdrawal symp-
toms. Those with a recent overdose were much more
likely to have witnessed an overdose, to have known
someone who died of an overdose, and to have experi-
enced a prior overdose (92.2% vs. 33.7%).
In a multivariable logistic regression model (Table 2),
characteristics and behaviors that were associated with
an increased risk of experiencing an overdose in the
past six months were using cocaine/crack in the past
six months (OR, 2.07; 95% CI = 1.25 to 3.45), using alcohol
in the past six months (OR, 1.90; 95% CI = 1.01 to 3.57),
experiencing serious withdrawal symptoms in the past
two months (OR, 2.70; 95% CI = 1.58 to 4.61), and having
overdosed more than six months ago (OR, 28.58; 95% CI
= 14.10 to 57.96). Younger age was associated with an
increased risk of experiencing an overdose in the past
six months. The c-statistic for the adjusted logistic
ACAD EMERG MED  July 2007, Vol. 14, No. 7  www.aemj.org 619Table 1
Bivariate Associations between Demographic Characteristics, Health Status, Drug Use and Risk Behaviors, and Overdose Experience,




Did Not Overdose in
Past Six Months
n % n % n %
Total 772 100.0 128 16.6 644 82.4
Demographic characteristics
Gender
Male 600 77.7 107 83.6 493 76.6
Female 167 21.6 21 16.4 146 22.7
Age (yr)
45+ 132 17.1 15 11.7 117 18.2
35–44 296 38.3 43 33.6 253 39.3
25–34 288 37.3 55 43.0 233 36.2
18–24 56 7.3 15 11.7 41 6.4
Race/ethnicity
White 88 11.4 16 12.5 72 11.2
African American 112 14.5 22 17.2 90 14.0
Hispanic 548 71.0 89 69.5 459 71.3
Asian or other race 24 3.1 1 0.8 23 3.6
Marital status
Never married 494 64.0 85 66.4 409 63.5
Married 115 14.9 17 13.3 98 15.2
Separated/widowed/divorced 162 21.0 26 20.3 136 21.1
Educational attainment
Less than high school 389 50.4 64 50.0 325 50.5
High school/equivalent or higher 380 49.2 64 50.0 316 49.1
Homeless in past six months
No 237 30.7 26 20.3 211 32.8
Yes 454 58.8 90 70.3 364 56.5
Health status
Self-reported health
Excellent/very good/good 301 39.0 39 30.5 262 40.7
Fair/poor 463 60.0 88 68.8 375 58.2
Human immunodeficiency virus status
Negative 585 75.8 97 75.8 488 75.8
Positive 89 11.5 10 7.8 79 12.3
Unknown 97 12.6 21 16.4 76 11.8
SF-36 composite scores, mean (SD)*
Physical functioning 74.4 (28.2) 72.3 (27.7) 74.8 (28.4)
Role limitations due to physical problems 56.8 (44.1) 44.8 (44.0) 59.2 (43.8)
Role limitations due to emotional problems 52.8 (45.7) 41.7 (43.1) 55.0 (46.0)
Social functioning 64.2 (31.7) 52.6 (31.6) 66.5 (31.3)
Bodily pain 60.4 (31.7) 51.7 (30.8) 62.1 (31.7)
Vitality 45.0 (23.3) 40.7 (22.6) 45.9 (23.4)
General health 46.5 (16.5) 42.3 (17.2) 47.3 (16.2)
Mental health 47.6 (22.6) 41.7 (21.1) 48.7 (22.7)
Drug use and risk behaviors
Length of drug using career (yr)
1–4 54 7.0 10 7.8 44 6.8
5–9 188 24.4 26 20.3 162 25.2
10–14 173 22.4 38 29.7 135 21.0
15–19 138 17.9 17 13.3 121 18.8
20+ 219 28.4 37 28.9 182 28.3
Used cocaine or crack in past six months
No 386 50.0 42 32.8 344 53.4
Yes 386 50.0 86 67.2 300 46.6
Used alcohol in past six months
No 223 28.9 19 14.8 204 31.7
Yes 549 71.1 109 85.2 440 68.3
Used tranquilizers or benzodiazepines in past
six months
No 566 73.3 78 60.9 488 75.8
Yes 206 26.7 50 39.1 156 24.2
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Overdosed in
Past Six Months
Did Not Overdose in
Past Six Months
n % n % n %
Number of types of drugs used in past
six months
1–5 272 35.2 26 20.3 246 38.2
6 or more 500 64.8 102 79.7 398 61.8
Any risky injection practices at last injectiony
No 440 57.0 58 45.3 382 59.3
Yes 327 42.4 70 54.7 257 39.9
Ever used a needle exchange
No 254 32.9 53 41.4 201 31.2
Yes 458 59.3 68 53.1 390 60.6
Any sexual risk behaviors in past two monthsz
No 382 49.5 48 37.5 334 51.9
Yes 389 50.4 80 62.5 309 48.0
Heroin dependentx
No 119 15.4 20 15.6 99 15.4
Yes 651 84.3 108 84.4 543 84.3
Cocaine dependentk
No 114 14.8 16 12.5 98 15.2
Yes 523 67.7 99 77.3 424 65.8
Serious withdrawal symptoms in past two months{
No 338 43.8 25 19.5 313 48.6
Yes 434 56.2 103 80.5 331 51.4
Methadone maintenance in past six months
No 371 48.1 58 45.3 313 48.6
Yes 307 39.8 58 45.3 249 38.7
Detoxification in past six months
No 292 37.8 48 37.5 244 37.9
Yes 471 61.0 78 60.9 393 61.0
Other drug treatment in past six months
No 48 6.2 10 7.8 38 5.9
Yes 724 93.8 118 92.2 606 94.1
Overdose experience
Overdosed prior to past six months
No 437 56.6 10 7.8 427 66.3
Yes 335 43.4 118 92.2 217 33.7
Ever witnessed an overdose
No 243 31.5 23 18.0 220 34.2
Yes 529 68.5 105 82.0 424 65.8
Ever personally known anyone who died
of an overdose
No 238 30.8 27 21.1 211 32.8
Yes 520 67.4 100 78.1 420 65.2
* Short Form-36 (SF-36) component scores range from 0 to 100, with higher scores indicating better health.
yRisky injection practices include splitting drug with needle and sharing cooker, cotton, rinse water, or needle.
zRisky sexual behaviors include having a sexual partner with hepatitis, giving or receiving drugs or money for sex, using condoms less than 80% of the
time with casual partners, and having more than one sexual partner.
xHeroin dependence was indicated by a score of R7 on the Severity of Dependence Scale.
kCocaine dependence was indicated by a score of R3 on the Severity of Dependence Scale.
{Serious withdrawal symptoms include stomach cramps, diarrhea, vomiting, and sweating.
Table 1
(continued)regression model was 0.886, demonstrating the high pre-
dictive ability of this model.43
DISCUSSION
In this cross sectional study of current heroin injectors,
we found that 16.6% had experienced at least one over-
dose in the past six months. Controlling for other risk
factors, drug users reporting a prior overdose were 29
times more likely to have a recent overdose than thosenot reporting a prior overdose. Other studies have dem-
onstrated that most drug users who overdose experience
multiple overdoses.40,44 Much as a prior myocardial in-
farction strongly predicts a current myocardial infarction
in the setting of anginal chest pain, these results suggest
that clinicians’ most important screening question for
overdose prevention may be ‘‘Have you ever overdosed
before?’’
We found that current heroin injectors who reported
using a variety of other drugs in the past six months
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consistent with earlier findings that polydrug use is a
strong predictor of both fatal and nonfatal overdose.4,15,18
We also found that drug users who had recently experi-
enced serious withdrawal symptoms were at greater
risk for a recent overdose. These withdrawal symptoms
may have resulted from voluntary or forced periods of
abstinence, including incarceration or drug treatment
Table 2
Unadjusted and Adjusted Models Predicting Overdose in the
Past Six Months, among Heroin Injectors
Unadjusted Adjusted*




45+ 1.00 — 1.00 —
35–44 1.33 0.71, 2.48 2.81 1.34, 5.91
25–34 1.84 1.00, 3.40 2.45 1.19, 5.05
18–24 2.85 1.28, 6.35 7.20 2.54, 20.41
Health status
SF-36 composite scoresy
Role limitations due to
physical problems
0.99 0.99, 1.00 1.00 0.99, 1.00
Drug use and risk
behaviors
Used cocaine or crack in
past six months
No 1.00 — 1.00 —
Yes 2.35 1.57, 3.50 2.07 1.25, 3.45
Used alcohol in past six
months
No 1.00 — 1.00 —
Yes 2.66 1.59, 4.45 1.90 1.01, 3.57
No. of types of drugs
used in past six
months
1–5 1.00 — 1.00 —
6 or more 2.43 1.53, 3.84 1.67 0.93, 2.99
Any sexual risk behaviors
in past two monthsz
No 1.00 — 1.00 —




No 1.00 — 1.00 —
Yes 3.90 2.45, 6.19 2.70 1.58, 4.61
Overdose experience
Overdosed prior to past
six months





* Total of 768 participants had nonmissing values for all variables in-
cluded in the adjusted model.
yShort Form-36 (SF-36) component scores range from 0 to 100, with
higher scores indicating better health.
zRisky sexual behaviors include having a sexual partner with hepatitis,
giving or receiving drugs or money for sex, using condoms less than
80% of the time with casual partners, and having more than one sexual
partner.
xSerious withdrawal symptoms include stomach cramps, diarrhea, vom-
iting, and sweating.attempts, although we did not find an independent effect
of enrollment in detoxification in the past six months on
the risk of recent overdose, as demonstrated in other
studies.23
In this sample, younger heroin injectors were at great-
est risk of experiencing a recent overdose. Although this
finding has been replicated in at least one other study,7
most studies have indicated greater risk of overdose
among older users.4,15,45 In these studies, age is often re-
flective of length of drug-using career, with overdose risk
increasing as length of drug-using career increases4;
this analysis of recent overdose captured current rather
than cumulative risk. It is also possible that in this
sample, younger age reflected unmeasured exposures
to social network characteristics that may increase risk
of overdose, including larger networks and conflicts
with network members19 or other unmeasured risk
behaviors.46
LIMITATIONS
These results must be considered preliminary due to sev-
eral limitations. These data are not prospective, therefore
the inferences that can be drawn regarding the predic-
tive nature of characteristics and behaviors for overdose
are limited. In addition, the timelines of some variables
differ, with some referring to the most recent injection
or behavior within the past two or six months. Although
these most recent behaviors likely reflect consistent con-
ditions and risk behaviors over the full duration of the
relevant time period, because drug use and risk behav-
iors tend to be relatively consistent over time,47 this is
not possible to demonstrate definitively. Interviewer-
administered surveys are subject to social desirability
bias, although other studies among drug users have
demonstrated high validity in self-reported drug use
and risk behaviors.47–49 Recall bias may also be present
in surveys, although this should be minimized by the fo-
cus on recent events. Some measures were used as prox-
ies for the underlying measures of interest; for example,
we did not have a direct measure of drug tolerance. Our
measures of physical and mental health were limited to a
general picture of perceived health and may not detect
asymptomatic disease that may nonetheless contribute
to risk of overdose. Finally, we assessed factors associ-
ated with recent nonfatal overdose; risk factors for fatal
overdose may be different.
CONCLUSIONS
The strongest independent predictor of a nonfatal over-
dose among habitual heroin injectors was having had
a prior overdose. Emergency physicians, often present
during overdose management and revival, may have a
unique opportunity to prevent future overdoses through,
for example, referral to agonist maintenance treatment,
delivery of overdose prevention education, or novel in-
terventions such as prescription of take-home nalox-
one.30 Prospective studies are needed to generate a
rigorous model to predict future overdose risk among
drug users.
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